TITLE

Drug Safety

PUB. DATE
March 1965
SOURCE
British Medical Journal;3/13/1965, Vol. 1 Issue 5436, p711
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64058005

 

Related Articles

  • Adverse Drug Events in Older Geriatric Patients. Bernabei, Roberto; Lattanzio, Fabrizia; Paolisso, Giuseppe // Drug Safety;2012 Supplement, Vol. 35 Issue 1, p1 

    A foreword to the journal "Drug Safety" is presented.

  • Drug safety and the CSM. Eaton, K. // Journal of the Royal Society of Medicine;Jul1987, Vol. 80 Issue 7, p464 

    A letter to the editor is presented on an editorial about drug safety.

  • FDA wants more Rx safety data.  // Drug Topics;11/7/94, Vol. 138 Issue 21, p7 

    Reports on the requirement for drug manufacturers to submit safety reports to the Food and Drug Administration.

  • Perspectives on drug withdrawals. Rapoport, David // CMAJ: Canadian Medical Association Journal;7/19/2005, Vol. 173 Issue 2, p128 

    Presents a letter to the editor about drug prescription and drug safety.

  • Perspectives on drug withdrawals. Gorman, Diane C. // CMAJ: Canadian Medical Association Journal;7/19/2005, Vol. 173 Issue 2, p129 

    Presents a letter to the editor about drug prescription and drug safety.

  • Perspectives on drug withdrawals. Williams, Russell // CMAJ: Canadian Medical Association Journal;7/19/2005, Vol. 173 Issue 2, p129 

    Presents a letter to the editor about drug prescription and drug safety.

  • Demand for drug imports rises. Bloice, Carl // Revolution: The Journal for RNs & Patient Advocacy;Mar/Apr2004, Vol. 5 Issue 2, p8 

    Discusses the rise in the demand for drug imports in the United States. Prescription drug costs; Drug import safety; Safety systems for importing drugs.

  • Wise Owl's Drug Safety Kit. Long, Gigi // Library Media Connection;Aug/Sep2011, Vol. 30 Issue 1, p97 

    A review of the DVD "Wise Owl's Drug Safety Kit," on safety, drug use and medications, is presented.

  • Drug safety on trial.  // Nature;3/31/2005, Vol. 434 Issue 7033, p545 

    Comments on the failure of the U.S. Food and Drug Administration to check the safety of the approved drugs. Inability of drug companies to complete studies of the clinical safety and efficacy of the drugs in the market; Need for a better approach in assessing the safety of marketed drugs;...

  • Prescribing for Two. Schneider, Ellen Meyer // Dermatology Times;May2003, Vol. 24 Issue 5, p32 

    Focuses on special drug selection considerations for pregnant patients. Cosmetic drugs; Classes of drugs in relation to safety in pregnant patients.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics